Activity value 71afghanistan Buyer,Last transaction date:
2025-09-20
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for m/s taj mangal pharma ltd from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 9 transactions, with a transaction quantity of 103149.34 and a transaction weight of 0.
YearTransactionsQuantityWeight
20241119000
20259103149.340
Bill of lading data
<
1/10
>
Trade date
2025/09/20
B/L No.
tlce-sb-10749-20-09-2025
Suppliers
macter international pvt ltd.
Buyers
m/s taj mangal pharma ltd
POLs
tlce
PODs
——
Supply area
Pakistan
Purchas area
Afghanistan
Weight
——
Amount
45211951
Hs code
30043900
Product tags
medicine,ail,ore
Product description
MEDICINE ( MORE DETAILS AS PER INV )
Expand
Trade date
2025/08/16
B/L No.
qcme-sb-1018-16-08-2025
Suppliers
macter international pvt ltd.
Buyers
m/s taj mangal pharma ltd
m/s taj mangal pharma ltd is afghanistan Buyer,
and primarily engages in the import and export business of products such as ice,medicine,ail.
According to the 52wmb.com global trade database, as of 2025-09-20, the company has completed 10 international trades,
with its main trading regions covering pakistan etc.
The core products include HS30049099,HS30043900 etc,
and its main trading partners are macter international pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on m/s taj mangal pharma ltd is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.